Upregulation of angiotensin-(1-7) formation in human podocytes - enzyme activity assay upon fluid flow shear stress

Debora Kaiser-Graf1, Oliver Domenig2, Marko Poglitsch2

  • 1Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Plos One
|January 9, 2026
PubMed

Insights

The renin-angiotensin system impacts kidney function. In human podocytes, fluid shear stress increases angiotensin-(1-7) production, primarily via prolylcarboxypeptidase, offering insights into kidney disease mechanisms.

Area of Science:

  • Nephrology
  • Renal Physiology
  • Molecular Biology

Background:

  • The renin-angiotensin system (RAS) regulates renal hemodynamics and natriuresis.
  • Overactivation of RAS, particularly angiotensin II, causes kidney damage.
  • Angiotensin-(1-7) counter-regulates deleterious angiotensin II effects, but its conversion in human podocytes under hyperfiltration is poorly understood.

Purpose of the Study:

  • To investigate angiotensin II to angiotensin-(1-7) conversion in human podocytes under fluid flow shear stress.
  • To identify enzymes involved in this conversion process.
  • To understand mechanisms of podocyte damage in glomerular hyperfiltration.

Main Methods:

  • Cultured human podocytes were exposed to fluid flow shear stress and angiotensin II.
  • Mass spectrometry analyzed angiotensin-(1-7) formation in cell lysates and supernatants.
  • Selective enzyme inhibitors assessed the contribution of prolylcarboxypeptidase, angiotensin converting enzyme 2, and prolyl endopeptidase.

Main Results:

  • Fluid flow shear stress significantly increased angiotensin-(1-7) formation in podocyte lysates.
  • This conversion was predominantly mediated by prolylcarboxypeptidase activity.
  • Angiotensin converting enzyme 2 and prolyl endopeptidase showed limited contribution.

Conclusions:

  • Human podocytes convert angiotensin II to angiotensin-(1-7) under fluid shear stress.
  • Prolylcarboxypeptidase is the key enzyme in this intraglomerular RAS modulation.
  • Findings enhance understanding of the alternative RAS pathway in podocyte response to hyperfiltration.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.8K
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
5.1K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K